Simulations Plus, Inc. /
Immunetrics
Simulations Plus adds Immunetrics in completed merger
- Terms
- Not stated
- Stage
- Closed
What happened
Simulations Plus, Inc. completed its merger with Immunetrics, Inc. on June 16, 2023. Immunetrics specializes in quantitative systems pharmacology modeling and will operate as a wholly-owned subsidiary.
The agreement provides for cash consideration, including two future earn-out payments of up to $8.0 million tied to revenue milestones for 2023 and 2024.
The source
Everything on this page comes from the source below.
Simulations Plus adds Immunetrics in completed merger
This document is the source for the companies, stage and people on this page.
Original filingUnlock with ProTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Closed
The source this page is built from.
Published by the source
The source this page is built from.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request accessAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly